Polymorphisms of the ICAM-1 gene are associated with inflammatory bowel disease, regardless of the p-ANCA status

Clinical Immunology

Volumn 101, Issue 3, 2001, Pages 357-360

  Braun, C ^a   Zahn, R ^a   Martin, K ^a   Albert, E ^a   Folwaczny, C ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Crohn's disease; ICAM 1; p ANCA; Ulcerative colitis

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ALLELE; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DNA POLYMORPHISM; DOT HYBRIDIZATION; ENTERITIS; EXON; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; ULCERATIVE COLITIS;

EID: 0035209986     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.2001.5118     Document Type: Article

References (29)

1. Cell adhesion in the immune system
2. Transendothelial migration
3. Inhibition of human mixed lymphocyte reactions by monoclonal antibodies to intercellular adhesion molecule-1 (ICAM-1)
4. Intercellular adhesion molecule-2, a second counter-receptor for CD11a/CD18 (leukocyte function-associated antigen-1), provides a costimulatory signal for T-cell receptor-initiated activation of human T cells
5. Adhesion receptors in the immune system
6. Intercellular adhesion molecule-1 expression and cell signaling cascades
7. Polymorphisms and linkage analysis for ICAM-1 and the selectin gene cluster
8. Intercellular adhesion molecule-1 gene polymorphisms in Behcet's disease
9. Multiple sclerosis: The increased frequency of the ICAM-1 exon 6 gene point mutation genetic type K469
10. Adhesion molecule polymorphisms in chronic renal allograft failure
11. Intercellular adhesion molecule 1 gene associations with immunologic subsets of inflammatory bowel disease
12. Neutrophil autoantibodies in ulcerative colitis: Familial aggregation and genetic heterogeneity
13. Ulcerative colitis: A genetically heterogeneous disorder defined by genetic (HLA class II) and subclinical (antineutrophil cytoplasmic antibodies) markers
14. Distinct associations of HLA class II genes with inflammatory bowel disease
15. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease
16. Neutrophil autoantibodies: A genetic marker in primary sclerosing cholangitis and ulcerative colitis
17. Nonradioactive HLA class II typing using polymerase chain reaction and digoxigenin-11-2′-3′-dideoxy-uridinetriphosphate-labe led oligonucleotide probes
18. Antineutrophiland pancreatic autoantibodies in first-degree relatives of patients with inflammatory bowel disease
19. Polymorphisms in tumor necrosis factor and adhesion molecule genes in patients with inflammatory bowel disease: Associations with HLA-DR and -DQ alleles and subclinical markers
20. Familial empiric risk estimates of inflammatory bowel disease in Ashkenazi Jews
21. Geographic origin of Jewish patients with inflammatory bowel disease
22. Soluble interleukin-2 receptors, antineutrophil cytoplasmatic antibodies, and other autoantibodies in patients with ulcerative colitis
23. Role of antineutrophil cytoplasmic antibodies in an ethnically distinct population: Korean patients with ulcerative colitis
24. Antineutrophil antibodies in inflammatory bowel disease: Prevalence and diagnostic role
25. Antineutrophil antibodies in familial inflammatory bowel disease
26. Perinuclear neutrophil autoantibodies (p-ANCA) in unaffected relatives of patients with ulcerative colitis (UC). Suggestions against familial aggregation
27. Antineutrophil cytoplasmatic antibodies in relatives of patients with inflammatory bowel disease
28. Antibody "markers" in Crohn's disease: Opportunity or overstatement?
29. Expression of leukocyte adhesion molecules by mucosal mononuclear phagozytes in inflammatory bowel disease